Skip to main content
Top
Published in: BMC Health Services Research 1/2010

Open Access 01-07-2010 | Research

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand

Authors: Jomkwan Yothasamut, Choenkwan Putchong, Teera Sirisamutr, Yot Teerawattananon, Sripen Tantivess

Published in: BMC Health Services Research | Special Issue 1/2010

Login to get access

Abstract

Background

Screening tests for cervical cancer are effective in reducing the disease burden. In Thailand, a Pap smear program has been implemented throughout the country for 40 years. In 2008 the Ministry of Public Health (MoPH) unexpectedly decided to scale up the coverage of free cervical cancer screening services, to meet an ambitious target. This study analyzes the processes and factors that drove this policy innovation in the area of cervical cancer control in Thailand.

Methods

In-depth interviews with key policy actors and review of relevant documents were conducted in 2009. Data analysis was guided by a framework, developed on public policy models and existing literature on scaling-up health care interventions.

Results

Between 2006 and 2008 international organizations and the vaccine industry advocated the introduction of Human Papillomavirus (HPV) vaccine for the primary prevention of cervical cancer. Meanwhile, a local study suggested that the vaccine was considerably less cost-effective than cervical cancer screening in the Thai context. Then, from August to December 2008, the MoPH carried out a campaign to expand the coverage of its cervical cancer screening program, targeting one million women. The study reveals that several factors were influential in focusing the attention of policymakers on strengthening the screening services. These included the high burden of cervical cancer in Thailand, the launch of the HPV vaccine onto the global and domestic markets, the country’s political instability, and the dissemination of scientific evidence regarding the appropriateness of different options for cervical cancer prevention. Influenced by the country’s political crisis, the MoPH’s campaign was devised in a very short time. In the view of the responsible health officials, the campaign was not successful and indeed, did not achieve its ambitious target.

Conclusion

The Thai case study suggests that the political crisis was a crucial factor that drew the attention of policymakers to the cervical cancer problem and led the government to adopt a policy of expanding coverage of screening services. At the same time, the instability in the political system impeded the scaling up process, as it constrained the formulation and implementation of the policy in the later phase.
Literature
1.
go back to reference WHO: Cervical cancer, HPV and HPV vaccines. Key points for policy makers and health professionals. Geneva. 2007 WHO: Cervical cancer, HPV and HPV vaccines. Key points for policy makers and health professionals. Geneva. 2007
2.
go back to reference Durst M, Gissmann L, Ikenberg H, zur Hausen H: A Papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983, 80: 3812-3815. 10.1073/pnas.80.12.3812.PubMedCentralCrossRefPubMed Durst M, Gissmann L, Ikenberg H, zur Hausen H: A Papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983, 80: 3812-3815. 10.1073/pnas.80.12.3812.PubMedCentralCrossRefPubMed
3.
go back to reference Parry J: Controversial new vaccine to prevent cervical cancer. Bulletin of the World Health Organization. 2006, 84 (2): 86-7.PubMedCentralPubMed Parry J: Controversial new vaccine to prevent cervical cancer. Bulletin of the World Health Organization. 2006, 84 (2): 86-7.PubMedCentralPubMed
4.
go back to reference Gakidou E, Nordhagen S, Obermeyer Z: Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med. 2008, 5 (6): e132-10.1371/journal.pmed.0050132. 10.1371/journal. pmed.0050132PubMedCentralCrossRefPubMed Gakidou E, Nordhagen S, Obermeyer Z: Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med. 2008, 5 (6): e132-10.1371/journal.pmed.0050132. 10.1371/journal. pmed.0050132PubMedCentralCrossRefPubMed
5.
go back to reference Anorlu R: Cervical cancer: the sub-Saharan Africa perspective. Reproductive Health Matters. 2008, 16 (32): 41-9. 10.1016/S0968-8080(08)32415-X.CrossRefPubMed Anorlu R: Cervical cancer: the sub-Saharan Africa perspective. Reproductive Health Matters. 2008, 16 (32): 41-9. 10.1016/S0968-8080(08)32415-X.CrossRefPubMed
6.
go back to reference WHO: Cervical cancer screening in developing countries. Report of a WHO consultation. 2002 WHO: Cervical cancer screening in developing countries. Report of a WHO consultation. 2002
7.
go back to reference Garland S, Park S, Ngan H, Frazer I, Tay E: The need for public education on HPV and cervical cancer prevention in Asia: Opinions of experts at the AOGIN Conference. Vaccine. 2008, 26: 5435-40. 10.1016/j.vaccine.2008.07.077.CrossRefPubMed Garland S, Park S, Ngan H, Frazer I, Tay E: The need for public education on HPV and cervical cancer prevention in Asia: Opinions of experts at the AOGIN Conference. Vaccine. 2008, 26: 5435-40. 10.1016/j.vaccine.2008.07.077.CrossRefPubMed
8.
go back to reference Sriplung H, Wiangnon S, Sontipong S, Sumitsawan Y, Martin N: Cancer Incidence Trends in Thailand, 1989-2000. Asian Pacific Journal of Cancer Prevention. 2006, 7: 239-44.PubMed Sriplung H, Wiangnon S, Sontipong S, Sumitsawan Y, Martin N: Cancer Incidence Trends in Thailand, 1989-2000. Asian Pacific Journal of Cancer Prevention. 2006, 7: 239-44.PubMed
9.
go back to reference Sriamporn S, Khuhaprema T, Parkin M: Cervical cancer screening in Thailand: an overview. J Med Screen. 2006, 13 (Suppl 1): S39-S43.PubMed Sriamporn S, Khuhaprema T, Parkin M: Cervical cancer screening in Thailand: an overview. J Med Screen. 2006, 13 (Suppl 1): S39-S43.PubMed
10.
go back to reference Chumworathayi B, Limpaphayom K, Srisupundit S, Lumbiganon P: VIA and cryotherapy: Doing what's best. Journal of the Medical Association of Thailand. 2006, 89 (8): 1333-9.PubMed Chumworathayi B, Limpaphayom K, Srisupundit S, Lumbiganon P: VIA and cryotherapy: Doing what's best. Journal of the Medical Association of Thailand. 2006, 89 (8): 1333-9.PubMed
12.
go back to reference Putchong C: Cervical cancer prevention and control in views of stakeholders. HITAP Newsletter. 2008, 1 (3): 8-9. Putchong C: Cervical cancer prevention and control in views of stakeholders. HITAP Newsletter. 2008, 1 (3): 8-9.
13.
go back to reference Tomyabatra K: Is Visual Inspection with Acetic Acid (VIA) appropriate for Cervical Cancer Screening: Randomized Controlled Trial with Crossover Design. Bulletin of the Department of Medical Services. 2007, 32: 31-8. Tomyabatra K: Is Visual Inspection with Acetic Acid (VIA) appropriate for Cervical Cancer Screening: Randomized Controlled Trial with Crossover Design. Bulletin of the Department of Medical Services. 2007, 32: 31-8.
14.
go back to reference Kingdon J: Agendas Alternatives and Public Policy. Boston: Little Brown. 1984 Kingdon J: Agendas Alternatives and Public Policy. Boston: Little Brown. 1984
15.
go back to reference Mangham LJ, Hanson K: Scaling up in international health: what are the key issues?. Health Policy Plan. 2010, 25 (2): 85-96. 10.1093/heapol/czp066.CrossRefPubMed Mangham LJ, Hanson K: Scaling up in international health: what are the key issues?. Health Policy Plan. 2010, 25 (2): 85-96. 10.1093/heapol/czp066.CrossRefPubMed
16.
go back to reference Gilson L, Schneider H: Commentary: Managing scaling up: what are the key issues?. Health Policy Plan. 2010, 25 (2): 97-8. 10.1093/heapol/czp067.CrossRefPubMed Gilson L, Schneider H: Commentary: Managing scaling up: what are the key issues?. Health Policy Plan. 2010, 25 (2): 97-8. 10.1093/heapol/czp067.CrossRefPubMed
17.
go back to reference Sherris J, Argurto I, Arrossi S, Dzuba I, Gaffikin L, Herdman C, et al: Advocating for cervical cancer prevention. Int J Gynecol Obstet. 2005, 89 (Suppl 2): S46-S54. 10.1016/j.ijgo.2005.01.010.CrossRef Sherris J, Argurto I, Arrossi S, Dzuba I, Gaffikin L, Herdman C, et al: Advocating for cervical cancer prevention. Int J Gynecol Obstet. 2005, 89 (Suppl 2): S46-S54. 10.1016/j.ijgo.2005.01.010.CrossRef
20.
go back to reference The MoPH Information and Public Relations Office: The MoPH provides free cervical cancer screening service throughout Thailand for 116 days, from mother's day to father's day, for 1 million women. The information and public relations office, Ministry of Public Health. 2008 The MoPH Information and Public Relations Office: The MoPH provides free cervical cancer screening service throughout Thailand for 116 days, from mother's day to father's day, for 1 million women. The information and public relations office, Ministry of Public Health. 2008
21.
go back to reference Ngowsiri J: The uptake of the national program for cervical cancer screening. The meeting of the Task Force to Develop a System for Cervical Cancer Screening. 2008, Nonthaburi: National Health Security Office Ngowsiri J: The uptake of the national program for cervical cancer screening. The meeting of the Task Force to Develop a System for Cervical Cancer Screening. 2008, Nonthaburi: National Health Security Office
22.
go back to reference Fisher K, Bass E: Advocacy, information and communicating: Engaging stakeholders at all levels to prepare for the introduction of HPV vaccines. Stop cervical cancer: Accelerating global access to HPV vaccines. 2006, 12th-13th December 2006; London; 2006. Fisher K, Bass E: Advocacy, information and communicating: Engaging stakeholders at all levels to prepare for the introduction of HPV vaccines. Stop cervical cancer: Accelerating global access to HPV vaccines. 2006, 12th-13th December 2006; London; 2006.
25.
go back to reference Agosti J, Goldie S: Introducing HPV vaccine in developing countries - Key challenges and issues. New England Journal of Medicine. 2007, 356 (19): 1908-10. 10.1056/NEJMp078053.CrossRefPubMed Agosti J, Goldie S: Introducing HPV vaccine in developing countries - Key challenges and issues. New England Journal of Medicine. 2007, 356 (19): 1908-10. 10.1056/NEJMp078053.CrossRefPubMed
26.
go back to reference WHO: Preparing for the introduction of HPV vaccines. Policy and program guidance for countries. Geneva. 2006 WHO: Preparing for the introduction of HPV vaccines. Policy and program guidance for countries. Geneva. 2006
27.
go back to reference WHO: Human papillomavirus and HPV vaccines: Technical information for policy-makers and health professionals. Geneva: Department of Immunization, Vaccines and Biologicals. 2007 WHO: Human papillomavirus and HPV vaccines: Technical information for policy-makers and health professionals. Geneva: Department of Immunization, Vaccines and Biologicals. 2007
28.
go back to reference WHO-SEARO: Strategy to prevent cervical cancer: Report of a bi-regional consultation, April 11-13, 2007. New Delhi: WHO Regional Office for South-East Asia. 2007 WHO-SEARO: Strategy to prevent cervical cancer: Report of a bi-regional consultation, April 11-13, 2007. New Delhi: WHO Regional Office for South-East Asia. 2007
29.
go back to reference Family Health International: HPV vaccines - New Tools in the Prevention of cervical cancer and other HPV disease in Asia and the Pacific. 2006, 2nd November 2006; Bangkok; 2006 Family Health International: HPV vaccines - New Tools in the Prevention of cervical cancer and other HPV disease in Asia and the Pacific. 2006, 2nd November 2006; Bangkok; 2006
30.
go back to reference Family Health International: Health outcomes research: How can it assist decision-making for the prevention of cervical cancer and other HPV disease in Asia and the Pacific?. 2008, 12th February 2008; Bangkok; 2008 Family Health International: Health outcomes research: How can it assist decision-making for the prevention of cervical cancer and other HPV disease in Asia and the Pacific?. 2008, 12th February 2008; Bangkok; 2008
31.
go back to reference Roughead E, Gilbert A, Vitry A: The Australian funding debate on quadrivalent HPV vaccine: A case study for the national pharmaceutical policy. Health Policy. 2008, 88 (2-3): 250-7. 10.1016/j.healthpol.2008.03.012.CrossRefPubMed Roughead E, Gilbert A, Vitry A: The Australian funding debate on quadrivalent HPV vaccine: A case study for the national pharmaceutical policy. Health Policy. 2008, 88 (2-3): 250-7. 10.1016/j.healthpol.2008.03.012.CrossRefPubMed
34.
go back to reference Tolhurst R, Zhang T, Yang H, Gao J, Tang S: Factors affecting the implementation of health legislation and its impact on the rural poor in China: A case study of implementation of the maternal and infant health care law in two poor counties. Int J Health Plann Manage. 2004, 19: 247-265. 10.1002/hpm.761.CrossRefPubMed Tolhurst R, Zhang T, Yang H, Gao J, Tang S: Factors affecting the implementation of health legislation and its impact on the rural poor in China: A case study of implementation of the maternal and infant health care law in two poor counties. Int J Health Plann Manage. 2004, 19: 247-265. 10.1002/hpm.761.CrossRefPubMed
35.
go back to reference Skocpol T: The rise and resounding demise of Clinton Plan. Health Affairs. 1995, Spring, 66-85. 10.1377/hlthaff.14.1.66. Skocpol T: The rise and resounding demise of Clinton Plan. Health Affairs. 1995, Spring, 66-85. 10.1377/hlthaff.14.1.66.
36.
go back to reference Hanson K, Ransom M, Oliveira-Cruz V, Mills A: Expanding access to priority health interventions: a framework for understanding the constraints to scaling-up. Journal of International Development. 2003, 15: 1-14. 10.1002/jid.963.CrossRef Hanson K, Ransom M, Oliveira-Cruz V, Mills A: Expanding access to priority health interventions: a framework for understanding the constraints to scaling-up. Journal of International Development. 2003, 15: 1-14. 10.1002/jid.963.CrossRef
37.
go back to reference Collins C, Green A, Hunter D: Health sector reform and the interpretation of policy context. Health Policy. 1999, 47: 69-83. 10.1016/S0168-8510(99)00003-2.CrossRefPubMed Collins C, Green A, Hunter D: Health sector reform and the interpretation of policy context. Health Policy. 1999, 47: 69-83. 10.1016/S0168-8510(99)00003-2.CrossRefPubMed
38.
go back to reference Crichton J: Changing fortunes: analysis of fluctuating policy space for family planning in Kenya. Health Policy Plan. 2008, 23: 339-350. 10.1093/heapol/czn020.PubMedCentralCrossRefPubMed Crichton J: Changing fortunes: analysis of fluctuating policy space for family planning in Kenya. Health Policy Plan. 2008, 23: 339-350. 10.1093/heapol/czn020.PubMedCentralCrossRefPubMed
39.
go back to reference Gilson L, Doherty J, Lake S, McIntyre D, Mwikisa C, Thomas S: The SAZA study: implementing health financing reform in South Africa and Zambia. Health Policy Plan. 2003, 18 (1): 31-46. 10.1093/heapol/18.1.31.CrossRefPubMed Gilson L, Doherty J, Lake S, McIntyre D, Mwikisa C, Thomas S: The SAZA study: implementing health financing reform in South Africa and Zambia. Health Policy Plan. 2003, 18 (1): 31-46. 10.1093/heapol/18.1.31.CrossRefPubMed
40.
go back to reference Gilson L, Raphaely N: The terrain of health policy analysis in low and middle income countries: a review of published literature 1994-2007. Health Policy Plan. 2008, 23 (5): 294-307. 10.1093/heapol/czn019.PubMedCentralCrossRefPubMed Gilson L, Raphaely N: The terrain of health policy analysis in low and middle income countries: a review of published literature 1994-2007. Health Policy Plan. 2008, 23 (5): 294-307. 10.1093/heapol/czn019.PubMedCentralCrossRefPubMed
Metadata
Title
Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
Authors
Jomkwan Yothasamut
Choenkwan Putchong
Teera Sirisamutr
Yot Teerawattananon
Sripen Tantivess
Publication date
01-07-2010
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue Special Issue 1/2010
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-10-S1-S5

Other articles of this Special Issue 1/2010

BMC Health Services Research 1/2010 Go to the issue